Evidence map›Paper›PMID 18323530›Full record

ReviewAmerican journal of respiratory cell and molecular biology2008

Cyclic AMP: master regulator of innate immune cell function.

Carlos H Serezani, Megan N Ballinger, David M Aronoff, Marc Peters-Golden

Open access · greenAbstract readReview
In one paragraph

Review in American journal of respiratory cell and molecular biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 231 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
231citing papers in PubMed, 1 pooled it
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

231 citing papers in PubMed, 1 synthesis or guideline pooled it, 402 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Article
  8. Article
  9. Special Issue "Alcohol and Inflammation".International journal of molecular sciences · 2026
    Article
  10. Article
  11. Article
  12. Simple biological controllers drive the evolution of soft modes.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

171 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Carlos H SerezaniDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Health, System, Ann Arbor, Michigan, USA.
Megan N Ballinger
David M Aronoff
Marc Peters-Golden
University of Michigan · USMichigan Medicine · USPulmonary and Critical Care Associates · US

Funding

LEUKOTRIENES AND PULMONARY ANTIBACTERIAL DEFENSER01HL058897 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PETERS-GOLDEN, MARC L · 1997 to 2012
$4.1M
Modulation of Lung Innate Immunity Prostaglandin E2K08HL078727 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ARONOFF, DAVID M · 2005 to 2009
$662k
Eicosanoids and lung macrophage antimicrobial mechanismsR56HL058897 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PETERS-GOLDEN, MARC L · 2008 to 2008
$383k
NHLBI NIH HHS HL058897NHLBI NIH HHS HL078727NHLBI NIH HHS K08 HL078727
6 · The paper itself

Abstract

Cyclic adenosine monophosphate (cAMP) was the original "second messenger" to be discovered. Its formation is promoted by adenylyl cyclase activation after ligation of G protein-coupled receptors by ligands including hormones, autocoids, prostaglandins, and pharmacologic agents. Increases in intracellular cAMP generally suppress innate immune functions, including inflammatory mediator generation and the phagocytosis and killing of microbes. The importance of the host cAMP axis in regulating antimicrobial defense is underscored by the fact that microbes have evolved virulence-enhancing strategies that exploit it. Many clinical situations that predispose to infection are associated with increases in cAMP, and therapeutic strategies to interrupt cAMP generation or actions have immunostimulatory potential. This article reviews the anatomy of the cAMP axis, the mechanisms by which it controls phagocyte immune function, microbial strategies to dysregulate it, and its clinical relevance.

Indexed as

Immunity, InnateAnimalsCyclic AMPHumansPhagocytosisSignal TransductionCyclic AMP

Identifiers

PMID18323530
PMCPMC2720142
OpenAlexW2054326230

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.